RABESAR-DSR Capsules

RABESAR-DSR Capsules – Dual Action Acid Control

RABESAR-DSR is a fixed-dose combination of **Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release)**, formulated to provide effective acid suppression along with improved gastrointestinal motility.

Scientific Rationale

Rabeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system. Domperidone enhances gastric motility and prevents reflux-related nausea by blocking peripheral dopamine receptors.

Mechanism of Action

Rabeprazole provides sustained acid suppression, promoting mucosal healing.
Domperidone improves gastric emptying and reduces reflux, nausea and bloating.

Indications and Benefits

Gastroesophageal reflux disease (GERD).
Acid peptic disorders and hyperacidity.
Functional dyspepsia with nausea or bloating.
Reflux-associated symptoms due to delayed gastric emptying.

Dosage

To be taken as directed by the physician, preferably before meals.

Safety Information

Generally well tolerated when used as prescribed.
Use under medical supervision in patients with hepatic impairment.
Not intended to replace medical advice or lifestyle modifications.

RABESAR-DSR offers reliable acid control with added prokinetic support for comprehensive symptom relief.